Cargando…

Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion

The novel coronavirus (COVID-19) has continued its global spread since the first documented case in late 2019 in Wuhan, China. With over 10 million cases and 500 thousand deaths reported worldwide, the need for an effective treatment regimen is evident. Historically, convalescent plasma (CP) has bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farhat, Ryan M., Mousa, Mohammad A., Daas, Eshaan J., Glassberg, Marilyn K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412951/ https://www.ncbi.nlm.nih.gov/pubmed/32850916 http://dx.doi.org/10.3389/fmed.2020.00435

Ejemplares similares

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective
por: Kanj, Saly, et al.
Publicado: (2021)

Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients
por: Roshandel, Elham, et al.
Publicado: (2021)

Convalescent plasma transfusion for pregnant patients with COVID-19
por: Mastroianni, Antonio, et al.
Publicado: (2021)

Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Farag, Youssef M.K.
Publicado: (2020)

Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19
por: Rodionov, Roman N, et al.
Publicado: (2021)

Usefulness of convalescent plasma transfusion for the treatment of severely ill COVID-19 patients in Pakistan
por: Khan, Tehmina Nafees Sonia, et al.
Publicado: (2021)

Therapeutic plasma exchange followed by convalescent plasma transfusion in critical COVID-19—An exploratory study
por: Jaiswal, Vinod, et al.
Publicado: (2021)

Convalescent Plasma Transfusion for the Treatment of COVID-19—Experience from Poland: A Multicenter Study
por: Moniuszko-Malinowska, Anna, et al.
Publicado: (2020)

In Reply — Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Joyner, Michael. J., et al.
Publicado: (2020)

Characterization of pathogen‐inactivated COVID‐19 convalescent plasma and responses in transfused patients
por: Weisser, Maja, et al.
Publicado: (2022)

Clinical nursing care protocol for convalescent plasma transfusion in patients with COVID-19
por: Maiara Ferreira Barreto Pires, Bruna, et al.
Publicado: (2023)

Convalescent plasma treatment of critically ill intensive care COVID‐19 patients
por: Lindemann, Monika, et al.
Publicado: (2021)

Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
por: Klassen, Stephen A., et al.
Publicado: (2021)

Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study
por: Kurtz, Pedro, et al.
Publicado: (2021)

ANAPHYLACTIC SHOCK IN A PREGNANT PATIENT WITH COVID-19 IN THE SETTING OF CONVALESCENT PLASMA TRANSFUSION
por: Mallari, Margaret, et al.
Publicado: (2020)

Analysis of Convalescent Plasma Transfusion in Children Confirmed with COVID-19: A Systemic Review
por: Casman, Casman, et al.
Publicado: (2022)

Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis
por: Barreira, Daniela Ferreira, et al.
Publicado: (2021)

Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis
por: Bansal, Vikas, et al.
Publicado: (2021)

Current Perspectives of convalescent plasma therapy in COVID-19
por: Sahu, Kamal Kant, et al.
Publicado: (2020)

Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Chaudhary, Sachin, et al.
Publicado: (2020)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

Corrigendum: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Chaudhary, Sachin, et al.
Publicado: (2021)

The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma
por: Ma, Tengfei, et al.
Publicado: (2022)

COVID-19convalescent plasma use in the oncology and geriatric patients: Ethical aspects in transfusion medicine
por: Bansal, N., et al.
Publicado: (2022)

Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates
por: Verma, Henu Kumar, et al.
Publicado: (2020)

Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini, Massimo, et al.
Publicado: (2021)

Use of convalescent plasma in the treatment of COVID-19
por: Joyner, Michael J., et al.
Publicado: (2023)

Late Treatment for COVID-19 With Convalescent Plasma
por: Senefeld, Jonathon W., et al.
Publicado: (2022)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report
por: Xu, Tian-min, et al.
Publicado: (2020)

First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia
por: Figlerowicz, Magdalena, et al.
Publicado: (2020)

Retraction: A review of convalescent plasma transfusion in COVID-19: Old wine reserved for special occasions
Publicado: (2021)

Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment
por: Karaba, Andrew H., et al.
Publicado: (2023)

The Emerging Role of Convalescent Plasma in the Treatment of COVID-19
por: Psaltopoulou, Theodora, et al.
Publicado: (2020)

Treatment for emerging viruses: Convalescent plasma and COVID-19
por: Brown, Bethany L., et al.
Publicado: (2020)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
por: Kirenga, Bruce, et al.
Publicado: (2021)

Early Outpatient Treatment for Covid-19 with Convalescent Plasma
por: Sullivan, David J., et al.
Publicado: (2022)

Reply to ‘Use of convalescent plasma in the treatment of COVID-19’
por: Murakami, Naoka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hnatgs2h4bue8v4nctoq41fh7t